Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT04260958
Active, not recruiting Not applicable

Remote Exercise SWEDEHEART Study

NCT04260958 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2020-02-03
Last updated
2026-07-07

Condition(s) studied

Myocardial Infarction

Investigational drug(s) / intervention(s)

Exercise-based cardiac rehabilitation

Exercise-based cardiac rehabilitation: The exercise program (remote/centre-based) will be standardized. An exCR-program is defined as at least 24 supervised sessions, with a total session length of 60 minutes, for at least 3 months, with possibility to complete missed sessions the 4th month. Each exercise session includes at least 20 min of aerobic exercise, intensity 13-17 on Borg´s rating of perceived exertion (RPE)-scale ≈ 60% - 85% of VO2max or 70 - 95% of maximal heart rate. In addition, each exercise session includes 1-3 sets of 8-10 upper and/or lower limb exercises in 10-15 repetitions, 40-80% of 1 repetition maximum. Attending ≥75% of the 24 sessions over a 4-month period will be considered as successful.

Study summary

The overall aim of the study is to evaluate if remote video exercise-based cardiac rehabilitation (exCR), offered as an alternative to centre-based exCR, can increase participation in exCR sessions post myocardial infarction (MI).

Eligibility

Sex
ALL
Min age
18 Years
Max age
79 Years
Healthy volunteers
No
Inclusion Criteria: * Written informed consent * Diagnosis of type 1 myocardial infarction (AMI) * Age 18-79 years at discharge from hospital Exclusion Criteria: * Patients with incomplete coronary revascularization defined as at least one remaining hemodynamically significant stenosis * Severe valve or structural heart disease * Severe heart failure (NYHA III - IV) * Serious arrythmias * Inability to understand Swedish * No internet access at home (only applicable for patients in the intervention group who wants to perform remote exCR) * Pathological exercise test indicating high risk for adverse events during exCR * More than 6 months between discharge form hospital and screening * Any other condition that may interfere with the possibility for the patient to comply with the study protocol

Primary outcome measure(s)

Trial sites (25)

FacilityCityRegionStatus
Södra Älvsborg Hospital Borås Sweden
Mälarsjukhuset Eskilstuna Sweden
Falun hospital Falun Sweden
Gällivare Hospital Gällivare Sweden
Gävle Hospital Gävle Sweden
Angered Hospital Gothenburg Sweden
Sahlgrenska University Hospital Östra Gothenburg Sweden
Sahlgrenska University Hospital Gothenburg Sweden
Hässleholm Hospital Hässleholm Sweden
Jönköping Ryhov hospital Jönköping Sweden
Kalix hospital Kalix Sweden
Kalmar Hospital Kalmar Sweden
Kungälv Hospital Kungälv Sweden
Lindesberg Hospital Lindesberg Sweden
Linköping University Hospital Linköping Sweden
Ljungby Hospital Ljungby Sweden
Sunderbyn hospital Luleå Sweden
Skåne University hospital Lund Sweden
Skåne University Hospital Malmö Malmö Sweden
Östersund hospital Östersund Sweden
Capio St Göran Hospital Stockholm Sweden
Karolinska University Hospital Stockholm Sweden
Sundsvall hospital Sundsvall Sweden
Uppsala University Hopsital Uppsala Sweden
Värnamo hospital Värnamo Sweden

More Sahlgrenska University Hospital trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04260958 on ClinicalTrials.gov ↗ ← All trials in Sweden